Xiaolan L. Feng

Vancouver Island Centre
Victoria, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Journal: Cancer medicine

Published: September 09, 2025

Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.

Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 27, 2025

Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra-Abdominal Sarcoma: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Whole Abdominal Radiotherapy Is Tolerable and Effective in Children and Young Adults With Intra-Abdominal Sarcoma: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Journal: Pediatric blood & cancer

Published: January 01, 2025

A Dramatic Clinical Response to Trastuzumab-Deruxtecan in a Patient with HER-2 Low Breast Cancer with Untreated Leptomeningeal Metastasis and Hydrocephalus.

A Dramatic Clinical Response to Trastuzumab-Deruxtecan in a Patient with HER-2 Low Breast Cancer with Untreated Leptomeningeal Metastasis and Hydrocephalus.

Journal: Current oncology (Toronto, Ont.)

Published: December 26, 2024

Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications.

Genomic and transcriptomic landscapes of metastatic neuroendocrine neoplasms from distinct primary sites and their clinical implications.

Journal: Scientific reports

Published: August 09, 2024

Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119].

Corrigendum to "Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study" [Eur. J. Cancer, vol. 205 (2024) 114119].

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 09, 2024

Treatment differences and long-term outcomes in adults and children with Ewing sarcoma.

Treatment differences and long-term outcomes in adults and children with Ewing sarcoma.

Journal: Cancer epidemiology

Published: March 30, 2024

Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.

Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 25, 2024

Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.

Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.

Journal: Therapeutic advances in medical oncology

Published: March 22, 2024

Development and calibration of a multi-delay coherence imaging diagnostic on the MAST-U tokamak.

Development and calibration of a multi-delay coherence imaging diagnostic on the MAST-U tokamak.

Journal: The Review of scientific instruments

Published: February 27, 2024

Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment.

Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with "Hot" Tumor Immune Microenvironment.

Journal: Cancers

Published: June 24, 2023

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Journal: Cancer medicine

Published: March 21, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026